These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

58 related items for PubMed ID: 9200339

  • 1. Prolonged prophylaxis in postoperative medicine.
    Bergqvist D.
    Semin Thromb Hemost; 1997; 23(2):149-54. PubMed ID: 9200339
    [Abstract] [Full Text] [Related]

  • 2. High incidence of in-hospital pulmonary embolism following joint arthroplasty with dalteparin prophylaxis.
    Kerr J, Linkins LA.
    Thromb Haemost; 2010 Jan; 103(1):123-8. PubMed ID: 20062935
    [Abstract] [Full Text] [Related]

  • 3. Deep vein thrombosis prophylaxis in the outpatient setting: preventing complications following hospital discharge.
    Turpie AG.
    Orthopedics; 1995 Jul; 18 Suppl():15-7. PubMed ID: 7479420
    [Abstract] [Full Text] [Related]

  • 4. Incidence, natural history and risk factors of deep vein thrombosis in elective knee arthroscopy.
    Delis KT, Hunt N, Strachan RK, Nicolaides AN.
    Thromb Haemost; 2001 Sep; 86(3):817-21. PubMed ID: 11583313
    [Abstract] [Full Text] [Related]

  • 5. Ximelagatran for the prevention of venous thromboembolism following elective hip or knee replacement surgery.
    Colwell C, Mouret P.
    Semin Vasc Med; 2005 Aug; 5(3):266-75. PubMed ID: 16123914
    [Abstract] [Full Text] [Related]

  • 6. Postoperative deep vein thrombosis prophylaxis: a retrospective analysis in 1000 consecutive hip fracture patients treated in a community hospital setting.
    Ennis RS.
    J South Orthop Assoc; 2003 Aug; 12(1):10-7. PubMed ID: 12735619
    [Abstract] [Full Text] [Related]

  • 7. Cost implications of low molecular weight heparins as prophylaxis following total hip and knee replacement.
    Bell GK, Goldhaber SZ.
    Vasc Med; 2001 Aug; 6(1):23-9. PubMed ID: 11358156
    [Abstract] [Full Text] [Related]

  • 8. Out of hospital antithrombotic prophylaxis after total hip replacement: low-molecular-weight heparin, warfarin, aspirin or nothing? A cost-effectiveness analysis.
    Sarasin FP, Bounameaux H.
    Thromb Haemost; 2002 Apr; 87(4):586-92. PubMed ID: 12008939
    [Abstract] [Full Text] [Related]

  • 9. Cost-effectiveness of enoxaparin versus warfarin prophylaxis against deep-vein thrombosis after total hip replacement.
    O'Brien BJ, Anderson DR, Goeree R.
    CMAJ; 1994 Apr 01; 150(7):1083-90. PubMed ID: 8137188
    [Abstract] [Full Text] [Related]

  • 10. Physician practices in the prevention of deep vein thrombosis: the MassPRO DVT Study.
    Anderson FA, Audet AM.
    Orthopedics; 1996 Aug 01; 19 Suppl():9-11. PubMed ID: 8856785
    [Abstract] [Full Text] [Related]

  • 11. Prolonged thromboprophylaxis following hip replacement surgery--results of a double-blind, prospective, randomised, placebo-controlled study with dalteparin (Fragmin).
    Dahl OE, Andreassen G, Aspelin T, Müller C, Mathiesen P, Nyhus S, Abdelnoor M, Solhaug JH, Arnesen H.
    Thromb Haemost; 1997 Jan 01; 77(1):26-31. PubMed ID: 9031444
    [Abstract] [Full Text] [Related]

  • 12. Incidence of posthospitalization proximal deep venous thrombosis after total hip arthroplasty. A pilot study.
    Trowbridge A, Boese CK, Woodruff B, Brindley HH, Lowry WE, Spiro TE.
    Clin Orthop Relat Res; 1994 Feb 01; (299):203-8. PubMed ID: 8119019
    [Abstract] [Full Text] [Related]

  • 13. The rationale for long-term prophylaxis of venous thromboembolism.
    Agnelli G, Mancini GB, Biagini D.
    Orthopedics; 2000 Jun 01; 23(6 Suppl):s643-6. PubMed ID: 10875429
    [Abstract] [Full Text] [Related]

  • 14. Risk of clinical pulmonary embolism after joint surgery in patients receiving low-molecular-weight heparin prophylaxis in hospital: a 10-year prospective register of 3,954 patients.
    Dahl OE, Gudmundsen TE, Bjørnarå BT, Solheim DM.
    Acta Orthop Scand; 2003 Jun 01; 74(3):299-304. PubMed ID: 12899550
    [Abstract] [Full Text] [Related]

  • 15. Pre-operative plasma levels of thrombin-antithrombin III complexes correlate with the development of venous thrombosis after major hip or knee surgery.
    Ginsberg JS, Brill-Edwards P, Panju A, Patel A, McGinnis J, Smith F, Dale I, Johnston M, Ofosu F.
    Thromb Haemost; 1995 Aug 01; 74(2):602-5. PubMed ID: 8584991
    [Abstract] [Full Text] [Related]

  • 16. Extended-duration thromboprophylaxis with enoxaparin after arthroscopic surgery of the anterior cruciate ligament: a prospective, randomized, placebo-controlled study.
    Marlovits S, Striessnig G, Schuster R, Stocker R, Luxl M, Trattnig S, Vécsei V.
    Arthroscopy; 2007 Jul 01; 23(7):696-702. PubMed ID: 17637403
    [Abstract] [Full Text] [Related]

  • 17. [Clinical risk factors for deep vein thrombosis after total hip and knee arthroplasty].
    Guan ZP, Lü HS, Chen YZ, Song YN, Qin XL, Jiang J.
    Zhonghua Wai Ke Za Zhi; 2005 Oct 15; 43(20):1317-20. PubMed ID: 16271243
    [Abstract] [Full Text] [Related]

  • 18. Preventing DVT following total knee replacement: a review of recent clinical trials.
    Fitzgerald RH.
    Orthopedics; 1995 Jul 15; 18 Suppl():10-1. PubMed ID: 7479418
    [Abstract] [Full Text] [Related]

  • 19. A dose ranging study to evaluate dermatan sulphate in preventing deep vein thrombosis following total hip arthroplasty.
    Cohen AT, Phillips MJ, Edmondson RA, Skinner JA, Das SK, Cooper DJ, Thomas EM, Melissari E, Kakkar VV.
    Thromb Haemost; 1994 Dec 15; 72(6):793-8. PubMed ID: 7740443
    [Abstract] [Full Text] [Related]

  • 20. Extended thromboprophylaxis with low-molecular-weight heparins after hospital discharge in high-risk surgical and medical patients: a review.
    Huo MH, Muntz J.
    Clin Ther; 2009 Jun 15; 31(6):1129-41. PubMed ID: 19695383
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.